http://www.novavax.com
Novavax, Inc. Company Intro
Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Using innovative proprietary recombinant nanoparticle vaccine technology, we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats. More...
Industry
Healthcare
Novavax, Inc. Headquaters
21 Firstfield Road
Gaithersburg,20878
United States
Novavax, Inc. Share price
16 Apr 2021 02:17 GMT
$202.11
0.77 (0.38 %)
Novavax, Inc. Market cap
$14.926 B
WMC RANKING
2021
Novavax, Inc. # 97
BiotechnologyLatest Novavax, Inc. News
03 Mar 2021
Gear up for the change! Novavax Inc. (NVAX) has hit the volume of 6269874
At the end of the latest market close, Novavax Inc. (NVAX) was valued at $240.29. In that particular session, Stock kicked-off at the price of $225.75 while ...
03 Mar 2021
Novavax Inc. [NVAX] moved down -14.27: Why It's Important ...
Novavax Inc. [NASDAQ: NVAX] stock went on a downward path that fall over -14.27% on Tuesday, amounting to a one-week price decrease of less than ...
WMC Market Score
WMC Market to Revenue Score
Novavax, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Novavax, Inc. | USD | $50,238 | $142,870 | $-93,258 | $149,260B | 97 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $529,920B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,205,683 | $2,599,993 | $2,711,647 | $572,250B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,069,900 | $2,656,500 | $603,400 | $348,030B | 3 |
| Incyte Corporation | USD | $2,229,409 | $1,622,822 | $446,906 | $182,910B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Novavax, Inc. Social Followers vs Top 4 Industry Competitors
Novavax, Inc. Post vs Top 4 Industry Competitors
Novavax, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Novavax, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Novavax, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Novavax, Inc. | 0.54 | 24.73 | 0.34 | 1 | 0 | 0 | 10.13 |
| Regeneron Pharmaceuticals, Inc. | 100 | 23.95 | 9.71 | 100 | 0 | 0 | 51.38 |
| Vertex Pharmaceuticals Incorporated | 67.14 | 35.08 | 2.77 | 86 | 0 | 0 | 47.55 |
| Alexion Pharmaceuticals, Inc. | 65.67 | 100 | 100 | 60 | 0 | 0 | 100 |
| Incyte Corporation | 24.12 | 4.95 | 0.25 | 2 | 0 | 0 | 2.93 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
